 "Indoco Remedies Q1 net profit jumps over nine-fold to Rs 17.04 cr")
Drug firm Indoco Remedies on Tuesday reported over nine-fold jump in its consolidated net profit to Rs 17.04 crore for the first quarter ended June 30, mainly on account of robust sales.
The company had posted a net profit of Rs 1.85 crore for the corresponding period previous fiscal, Indoco Remedies said in a BSE filing.
The consolidated revenue from operations of the company stood at Rs 266.80 crore for the quarter under consideration. It was Rs 247.18 crore for the same period a year ago, it added.
"In the first quarter, the company could register a growth of 7.9 per cent in revenues inspite of COVID-19 crisis. In these challenging times, our teams used digital platforms effectively to establish communication with the customers and maintained uninterrupted supplies of medicines in India and across the world," Indoco Remedies MD Aditi Panandikar said.
Shares of Indoco Remedies closed at Rs259.90per scrip on BSE, up 4.04 per cent from its previous close.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app